May 2005
Volume 46, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2005
Scleral Permeability of Dexamethasone–Fluorescein in a Collagen Gel Vehicle
Author Affiliations & Notes
  • H.F. Edelhauser
    Ophthalmology, Emory University Eye Center, Atlanta, GA
  • W. Brooks
    Ophthalmology, Emory University Eye Center, Atlanta, GA
  • D. Ghate
    Ophthalmology, Emory University Eye Center, Atlanta, GA
  • D.H. Geroski
    Ophthalmology, Emory University Eye Center, Atlanta, GA
  • D. DeVore
    Xium LLC, Chelmsford, MA
  • R.A. Eiferman
    VA Medical Center, Louisville, KY
  • Footnotes
    Commercial Relationships  H.F. Edelhauser, Xium LLC, Chemsford, MA F; W. Brooks, Xium LLC, Chemsford, MA F; D. Ghate, Xium LLC, Chemsford, MA F; D.H. Geroski, Xium LLC, Chemsford, MA F; D. DeVore, Xium LLC, Chemsford, MA P; R.A. Eiferman, Xium LLC, Chemsford, MA P.
  • Footnotes
    Support  R43–EY015588
Investigative Ophthalmology & Visual Science May 2005, Vol.46, 480. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      H.F. Edelhauser, W. Brooks, D. Ghate, D.H. Geroski, D. DeVore, R.A. Eiferman; Scleral Permeability of Dexamethasone–Fluorescein in a Collagen Gel Vehicle . Invest. Ophthalmol. Vis. Sci. 2005;46(13):480.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Intravitreal and posterior subtenon steroid injections are used to treat a variety of posterior segment conditions. Soluble collagen inserts impregnated with drugs have been used for localized drug delivery to the eye and other organs. A collagen gel impregnated with steroid should result in sustained drug delivery localized to the posterior segment and with the potential of easy removal should any complications arise. Purpose:To determine scleral permeability and continuous release of dexamethasone–fluorescein (DF) from high and low collagen gels and collagen film. Methods: Sections of sclera excised from moist–chamber stored human globes from the Georgia Eye Bank were mounted in a perfusion chamber. The pressure and temperature were maintained at 15 mm Hg and 36oC, respectively. A small depot (200 µL) of high or low collagen gel, or a 7.0 mm button of collagen film and 100 µL of BSS, was added to the episclera in a donor chamber. On the choroidal side of the sclera, BSS was perfused at a starting rate of 2.00 mL/min. and a running rate of 0.03 mL/min. Perfusate samples were collected in a fraction collector every half hour for a period of 24 hours. Concentrations of DF were measured using a fluorometer. Transscleral permeability Flux(µg/sec/cm2) was calculated using these concentrations. Results: Flux(µg/sec/cm2) for DF low collagen gel (20% collagen) was (Mean ± SD) 6.21 ± 0.87x10–04 (n=2), and for high collagen gel (40% collagen) was 6.39 ± 1.8x10–03 (n=3). Flux(µg/sec/cm2) for the 10–3.5 M collagen film was 7.39 ± 2.26x10–04 (n=4). Both gels and the collagen film showed a release over a 24 hour period. Conclusions:A continuous slow release of DF occurs with both high, low and film form of the collagen gel with the highest scleral diffusion occurring with the high collagen gel.

Keywords: sclera 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×